Occupational exposure during endovascular aneurysm repair (EVAR) and aortoiliac percutaneous transluminal angioplasty (PTA) procedures.


Journal

La Radiologia medica
ISSN: 1826-6983
Titre abrégé: Radiol Med
Pays: Italy
ID NLM: 0177625

Informations de publication

Date de publication:
Jun 2019
Historique:
received: 26 09 2018
accepted: 20 12 2018
pubmed: 24 1 2019
medline: 25 6 2019
entrez: 24 1 2019
Statut: ppublish

Résumé

The purpose of this study was to determine the radiation exposure of primary interventionalist's different body parts during endovascular aneurysm repair (EVAR) procedures and aortoiliac percutaneous transluminal angioplasty (PTA) procedures and to evaluate the efficacy of a radioprotective drape. Occupational doses for 36 consecutive aortoiliac PTA procedures and 17 consecutive EVAR procedures were estimated using thermoluminescence dosimetry (TLD) chips (TLD-200, Hashaw, Solon, OH). Effective dose (ED) was calculated using the Niklason algorithm. For the evaluation of a 0.25 mm Pb equivalent drape (Ecolab, Saint Paul, Minnesota, USA), experiments were performed using two physical anthropomorphic phantoms (Rando-Alderson Research Labs, CA, USA). Median ED for a typical EVAR and PTA procedure was 4.7 ± 1.4 μSv and 4.4 ± 3.6 μSv, respectively. The highest radiation doses were measured for the operator's hands in both procedures. Moreover, considerable doses were measured to the operator's head, eye lenses and thyroid. Due to the use of the drape, radiation exposure of primary operator's abdominal area, genitals, thyroid and eye lenses was reduced by an average of 59%, 60%, 65% and 59%, respectively. However, dose area product (DAP) and peak skin dose (PSD) were increased by 20% when part of the drape was placed into the X-ray field. During EVAR and PTA procedures, primary operator's organs are exposed to considerable radiation doses. Occupational radiation exposure can be reduced significantly with the proper use of a radioprotective drape.

Identifiants

pubmed: 30673929
doi: 10.1007/s11547-018-00985-8
pii: 10.1007/s11547-018-00985-8
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

539-545

Références

J Vasc Surg. 2000 Jan;31(1 Pt 2):S1-S296
pubmed: 10666287
Radiat Prot Dosimetry. 2004;111(3):271-4
pubmed: 15266088
J Vasc Surg. 2007 Sep;46(3):455-9
pubmed: 17826233
N Engl J Med. 2008 Jan 31;358(5):464-74
pubmed: 18234751
Health Phys. 2009 Sep;97(3):206-11
pubmed: 19667803
Curr Cardiol Rev. 2009 Jan;5(1):1-11
pubmed: 20066141
Cardiovasc Intervent Radiol. 2011 Aug;34(4):717-22
pubmed: 21069332
Catheter Cardiovasc Interv. 2012 Jan 1;79(1):97-102
pubmed: 21520391
Eur J Cardiothorac Surg. 2012 Aug;42(2):254-59; discussion 259-60
pubmed: 22290886
JAMA. 2012 Apr 18;307(15):1621-8
pubmed: 22511690
Radiology. 2012 Jul;264(1):278-84
pubmed: 22550308
Handb Exp Pharmacol. 2012;(210):547-63
pubmed: 22918746
Vasc Endovascular Surg. 2013 Aug;47(6):462-6
pubmed: 23853222
Eur J Vasc Endovasc Surg. 2013 Oct;46(4):424-30
pubmed: 23871303
JACC Cardiovasc Interv. 2013 Oct;6(10):1095-102
pubmed: 24156970
Eur J Vasc Endovasc Surg. 2014 Mar;47(3):268-72
pubmed: 24445087
Eur J Vasc Endovasc Surg. 2014 Oct;48(4):382-90
pubmed: 25042331
Cardiovasc Intervent Radiol. 2015 Jun;38(3):573-8
pubmed: 25280954
N Engl J Med. 2014 Nov 27;371(22):2101-8
pubmed: 25427112
Cardiovasc Intervent Radiol. 2015 Aug;38(4):827-32
pubmed: 25476871
Ann Vasc Surg. 2016 May;33:167-72
pubmed: 26902938
Phys Med. 2016 Aug;32(8):1019-24
pubmed: 27453204
Eur Radiol. 2017 Nov;27(11):4846-4856
pubmed: 28523354
Health Phys. 1994 Dec;67(6):611-5
pubmed: 7960781

Auteurs

Eleftherios Tzanis (E)

Department of Medical Physics, Medical School, University of Crete, P.O. Box 2208, 71003, Heraklion, Crete, Greece.

Dimitrios Tsetis (D)

Interventional Radiology Unit, Department of Radiology, University Hospital of Heraklion, Medical School, University of Crete, Crete, Greece.

Elias Kehagias (E)

Interventional Radiology Unit, Department of Radiology, University Hospital of Heraklion, Medical School, University of Crete, Crete, Greece.

Christos V Ioannou (CV)

Vascular Surgery Unit, Department of Cardiothoracic and Vascular Surgery, University Hospital of Heraklion, Medical School, University of Crete, Crete, Greece.

John Damilakis (J)

Department of Medical Physics, University Hospital of Heraklion, Medical School, Faculty of Medicine, University of Crete, P.O. Box 2208, 71003, Iraklion, Crete, Greece. john.damilakis@med.uoc.gr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH